| A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis L Kappos, EW Radue, P O'Connor, C Polman, R Hohlfeld, P Calabresi, ... New England Journal of Medicine 362 (5), 387-401, 2010 | 2935 | 2010 |
| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 2730 | 2014 |
| Natalizumab plus interferon beta-1a for relapsing multiple sclerosis RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... New England Journal of Medicine 354 (9), 911-923, 2006 | 1580 | 2006 |
| Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification K Hua, J Zhang, S Wakana, H Jiang, X Li, DS Reich, PA Calabresi, ... Neuroimage 39 (1), 336-347, 2008 | 1315 | 2008 |
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ... Annals of neurology 66 (4), 460-471, 2009 | 888 | 2009 |
| Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ... The Lancet 378 (9805), 1779-1787, 2011 | 840 | 2011 |
| Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis JB Fisher, DA Jacobs, CE Markowitz, SL Galetta, NJ Volpe, ... Ophthalmology 113 (2), 324-332, 2006 | 815 | 2006 |
| Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial PA Calabresi, EW Radue, D Goodin, D Jeffery, KW Rammohan, AT Reder, ... The Lancet Neurology 13 (6), 545-556, 2014 | 761 | 2014 |
| Saccade preparation inhibits reorienting to recently attended locations. RD Rafal, PA Calabresi, CW Brennan, TK Sciolto Journal of Experimental Psychology: Human perception and performance 15 (4), 673, 1989 | 710 | 1989 |
| Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis A Petzold, JF de Boer, S Schippling, P Vermersch, R Kardon, A Green, ... The Lancet Neurology 9 (9), 921-932, 2010 | 608 | 2010 |
| Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled … L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ... Nature medicine 6 (10), 1176-1182, 2000 | 581 | 2000 |
| Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA SS Soldan, R Berti, N Salem, P Secchiero, L Flamand, PA Calabresi, ... Nature medicine 3 (12), 1394-1397, 1997 | 562 | 1997 |
| Kv1. 3 channels are a therapeutic target for T cell-mediated autoimmune diseases C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, ... Proceedings of the National Academy of Sciences 103 (46), 17414-17419, 2006 | 560 | 2006 |
| Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008 | 538 | 2008 |
| The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS H Wulff, PA Calabresi, R Allie, S Yun, M Pennington, C Beeton, ... The Journal of clinical investigation 111 (11), 1703-1713, 2003 | 509 | 2003 |
| Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS? A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ... Annals of neurology 67 (4), 452-461, 2010 | 482 | 2010 |
| Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis E Gordon-Lipkin, B Chodkowski, DS Reich, SA Smith, M Pulicken, ... Neurology 69 (16), 1603-1609, 2007 | 466 | 2007 |
| Imaging outcomes for neuroprotection and repair in multiple sclerosis trials F Barkhof, PA Calabresi, DH Miller, SC Reingold Nature Reviews Neurology 5 (5), 256-266, 2009 | 460 | 2009 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 449 | 2019 |
| Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis LS Talman, ER Bisker, DJ Sackel, DA Long Jr, KM Galetta, JN Ratchford, ... Annals of neurology 67 (6), 749-760, 2010 | 402 | 2010 |
Shiv SaidhaJohns HopkinsVerified email at jhmi.edu
